91 – 99 of 99
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons
(
- Contribution to journal › Article
-
Mark
Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex
(
- Contribution to journal › Article
- 2002
-
Mark
L-DOPA-Induced Dyskinesia in the Intrastriatal 6-Hydroxydopamine Model of Parkinson's Disease: Relation to Motor and Cellular Parameters of Nigrostriatal Function.
(
- Contribution to journal › Article
-
Mark
Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.
(
- Contribution to journal › Article
-
Mark
Neuropathological and behavioral consequences of adeno-associated viral vector-mediated continuous intrastriatal neurotrophin delivery in a focal ischemia model in rats.
(
- Contribution to journal › Article
-
Mark
Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.
(
- Contribution to journal › Scientific review
- 2001
-
Mark
Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia
(
- Contribution to journal › Article
- 1997
-
Mark
Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease
(
- Contribution to journal › Scientific review